Drug Trial Radar · NCT04169321
Granzyme B PET Imaging Drug as a Predictor of Immunotherapy Response to Checkpoint Inhibitors
Last checked: Nov 20, 2026Latest source record: Oct 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
13
Actual
Start
Jun 16, 2020
Primary completion
Mar 30, 2025
Study completion Jun 9, 2025
Sponsor
- Lead sponsor
- Cytosite Biopharma Inc.Industry
- Sponsor type
- Industry
- Collaborators
- Massachusetts General Hospital; University of Alabama at Birmingham; Chang Gung Memorial Hospital
- First posted
- Nov 19, 2019
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Diagnostic
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
First in Human Safety of \[68Ga\]-NOTA-hGZP PET Imaging in subjects with cancer undergoing treatment with a checkpoint inhibitor either as a monotherapy of in combination I-O therapy
Conditions
- Solid Tumor, Unspecified, Adult
- Lymphoma
Interventions
Single ArmDrug
\[68Ga\]-NOTA-hGZP is a PET imaging agent.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of participants with clinically meaningful changes in physical examination findings, vital signs or blood chemistryTime frame: up to 4 to 6 hours post-injection
- Number of participants with changes in ECGTime frame: up to 4 to 6 hours post-injection
- Number of participants with treatment-related Adverse Events (AEs)Time frame: Between time of injection and 3 days post injection
Locations
3 sites in 2 countries. Site status is shown where the registry gives one.
University of Alabama at Birmingham
Birmingham, Alabama
Massachusetts General Hospital
Boston, Massachusetts
Chang-Gung Memorial Hospital
Taoyuan City, Guishan, Taiwan
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.